In a genetically obese melanocortin 4 receptor (MC4R)-deficient mouse model of NASH, anagliptin ameliorated fibrosis and reduced the number of liver tumors that developed after the mice were fed a Western-type diet. Here, MC4R is linked to metabolic dysfunction-associated steatohepatitis.